Kintor Pharmaceutical Limited (9939.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 791.81M |
| Enterprise Value | 843.67M |
| P/E Ratio | -3.77 |
| PEG Ratio | 0.98 |
| Price/Sales Ratio | 9.34 |
| Price/Book Ratio | 6.98 |
| Enterprise/Revenue | 10.65 |
| Enterprise/EBITDA | -5.19 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -2.44 |
| Operating Margin | -2.56 |
AD
Management Effectiveness
| Return On Assets | -0.59 |
| Return On Equity | -1.3 |
Income Statement
| Revenue | 32.68M |
| Revenue/Share | 0.16 |
| Gross Profit | 8.04M |
| EBITDA | -140.66M |
| Net Income | -200.11M |
| Diluted EPS | -0.44 |
Balance Sheet
| Total Cash | 31.79M |
| Total Cash/Share | 0.06 |
| Total Debt | 133.56M |
| Total Debt/Equity | 1.22 |
| Current Ratio | 0.26 |
| Book Value Per Share | 0.22 |
Price History
| 52-Week Change | -24.16 |
| 52-Week High | 4.7 |
| 52-Week Low | 1.61 |
| Moving Average 50 Days | 1.89 |
| Moving Average 200 Days | 2.4 |
Statistics
| Average Volume | 937,201 |
| Shares Outstanding | 468.9M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
